Basic Information
LncRNA/CircRNA Name | HOXD-AS1 |
Synonyms | HAGLR, HOXD-AS1, Mdgt |
Region | GRCh38_2:176164051-176188958 |
Ensemble | ENSG00000224189 |
Refseq | NR_033979 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, Western blot etc. |
Sample | cell lines (A549, H1703, SK-MES-1, NCI-H1299) |
Expression Pattern | up-regulated |
Function Description | HOXD-AS1 could negatively regulate the expression of miR-147a. miR-147a inhibition abrogated the effect of HOXD-AS1 knockdown on the proliferation and apoptosis of NSCLC cells. Furthermore, HOXD-AS1 positively regulated the expression of pRB (a tumor suppressor protein) in NSCLC cells. Taken together, our data indicated that HOXD-AS1 might be an oncogenic lncRNA that promotes proliferation of NSCLC and could be a therapeutic target in NSCLC. |
Pubmed ID | 29033588 |
Year | 2017 |
Title | hOXD-as1 functions as an oncogenic cerna to promote nsclc cell progression by sequestering mir-147a |
External Links
Links for HOXD-AS1 | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |